Stern Tal, Zelinger Einat, Hayouka Zvi
Institute of Biochemistry, Food Science and Nutrition, Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel.
Chem Commun (Camb). 2016 Jun 4;52(44):7102-5. doi: 10.1039/c6cc01438k. Epub 2016 May 10.
Methicillin-resistant Staphylococcus aureus (MRSA) is a biofilm-forming pathogen that can cause serious health complications in humans, ranging from minor to life-threatening infections. The challenge of successfully combating biofilms requires the discovery of compounds with a novel mode of action. We have recently developed sequence-random hydrophobic-cationic peptides that display a broad antibacterial activity. In the current study we show that our novel compounds are capable of controlling and managing MRSA biofilms and might be used as lead biofilm inhibitor candidates for further studies.
耐甲氧西林金黄色葡萄球菌(MRSA)是一种形成生物膜的病原体,可导致人类出现严重的健康并发症,从轻微感染到危及生命的感染不等。成功对抗生物膜的挑战需要发现具有新作用方式的化合物。我们最近开发了具有序列随机性的疏水阳离子肽,这些肽具有广泛的抗菌活性。在当前研究中,我们表明我们的新型化合物能够控制和管理MRSA生物膜,并且可能用作进一步研究的潜在生物膜抑制剂先导物。